KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Amortization of Deferred Charges (2020)

Palvella Therapeutics (PVLA) has disclosed Amortization of Deferred Charges for 2 consecutive years, with $199000.0 as the latest value for Q1 2020.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A to $199000.0 in Q1 2020 year-over-year; TTM through Mar 2020 was $746202.0, a 18.55% increase, with the full-year FY2019 number at $408000.0, changed N/A from a year prior.
  • Amortization of Deferred Charges was $199000.0 for Q1 2020 at Palvella Therapeutics, down from $365251.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $199000.0 in Q1 2020 to a low of $199000.0 in Q1 2020.